131 related articles for article (PubMed ID: 38161050)
21. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
22. Analysis of V(H)-D-J(H) gene transcripts in B cells infiltrating the salivary glands and lymph node tissues of patients with Sjögren's syndrome.
Gellrich S; Rutz S; Borkowski A; Golembowski S; Gromnica-Ihle E; Sterry W; Jahn S
Arthritis Rheum; 1999 Feb; 42(2):240-7. PubMed ID: 10025917
[TBL] [Abstract][Full Text] [Related]
23. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.
Voulgarelis M; Skopouli FN
Clin Rev Allergy Immunol; 2007 Jun; 32(3):265-74. PubMed ID: 17992593
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of Sjögren's syndrome: what we know and what we should learn.
Tzioufas AG; Kapsogeorgou EK; Moutsopoulos HM
J Autoimmun; 2012 Aug; 39(1-2):4-8. PubMed ID: 22326205
[TBL] [Abstract][Full Text] [Related]
25. Autophagy occurs in lymphocytes infiltrating Sjögren's syndrome minor salivary glands and correlates with histological severity of salivary gland lesions.
Colafrancesco S; Vomero M; Iannizzotto V; Minniti A; Barbati C; Arienzo F; Mastromanno L; Colasanti T; Izzo R; Nayar S; Pipi E; Cerbelli B; Giordano C; Ciccia F; Conti F; Valesini G; Barone F; Priori R; Alessandri C
Arthritis Res Ther; 2020 Oct; 22(1):238. PubMed ID: 33050949
[TBL] [Abstract][Full Text] [Related]
26. FcRL4
Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
[TBL] [Abstract][Full Text] [Related]
27. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
28. Detection of clonally expanded salivary gland lymphocytes in Sjögren's syndrome.
Freimark B; Fantozzi R; Bone R; Bordin G; Fox R
Arthritis Rheum; 1989 Jul; 32(7):859-69. PubMed ID: 2546568
[TBL] [Abstract][Full Text] [Related]
29. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
30. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
[TBL] [Abstract][Full Text] [Related]
31. Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjögren's syndrome.
Yoshimoto K; Fujimoto T; Itaya-Hironaka A; Miyaoka T; Sakuramoto-Tsuchida S; Yamauchi A; Takeda M; Kasai T; Nakagawara K; Nonomura A; Takasawa S
Clin Exp Immunol; 2013 Oct; 174(1):1-9. PubMed ID: 23701206
[TBL] [Abstract][Full Text] [Related]
32. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome.
Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L
Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207
[TBL] [Abstract][Full Text] [Related]
33. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
34. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
[TBL] [Abstract][Full Text] [Related]
35. High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients.
Pisa EK; Pisa P; Kang HI; Fox RI
J Exp Med; 1991 Nov; 174(5):1245-50. PubMed ID: 1940802
[TBL] [Abstract][Full Text] [Related]
36. Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sjögren's syndrome.
Skarstein K; Jensen JL; Galtung H; Jonsson R; Brokstad K; Aqrawi LA
Autoimmunity; 2019; 52(7-8):242-250. PubMed ID: 31661985
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
38. B cell MALT lymphoma diagnosed by labial minor salivary gland biopsy in patients screened for Sjögren's syndrome.
Van Mello NM; Pillemer SR; Tak PP; Sankar V
Ann Rheum Dis; 2005 Mar; 64(3):471-3. PubMed ID: 15708896
[TBL] [Abstract][Full Text] [Related]
39. B-cell lymphoproliferation in primary Sjögren's syndrome.
Tzioufas AG
Clin Exp Rheumatol; 1996; 14 Suppl 14():S65-70. PubMed ID: 8722203
[TBL] [Abstract][Full Text] [Related]
40. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
